In a bold move into relatively uncharted waters, drug researchers are delving into the curative effects of the psychotropic drug 5-MeO-DMT (also called mebufotenin) and studying its potential as a ...

Cosmo Feilding-Mellen is the co-founder and CEO at Beckley Psytech, a UK-based biotech company developing psychedelic compounds. Based on a growing body of clinical research, psychedelic-assisted ...

Clinical-stage biopharmaceutical company GH Research PLC (NASDAQ:GHRS) announced positive results from recent clinical trials of its leading 5-MeO-DMT formula, a therapy candidate for patients ...

Beckley Psytech recently announced that they have dosed the first healthy volunteers in their Phase I trial assessing the safety and efficacy of an intranasally delivered formulation of ...

5-MeO-DMT is a potent and fast-acting psychedelic, which is naturally produced by the Sonoran Desert toad as well as some species of plants. Its short duration –from 20 minutes to one hour– is giving ...

This article was originally featured on Undark. When Johannes Reckweg arrived in the Netherlands in 2016 to work on his master’s program in neuropsychology, he didn’t expect to learn about a ...

5-MeO-DMT is a psychoactive tryptamine which was first identified in the mid 20th Century as a chemical in a South American plant entheogen. It is a common constituent of many different plants and has ...

MADISON, Wis.--(BUSINESS WIRE)--Usona Institute has published a multigram-scale process describing the synthesis of 5-MeO-DMT in the open-access journal ACS Omega. The newly developed procedure ...